Cigna Corporation
NYSE:CIMedical - Healthcare Plans
Healthcare
$270.90 -1.56%
-$4.44 today
- Market cap
- $71.38B
- Beta
- 0.30
- P/E (TTM)
- 11.7
- EPS (TTM)
- $23.95
- Dividend yield
- 2.19%
52W Low $239.51High $338.89
Volume 2.62M
Average 1.61M
Income Statement
Follow revenue through to earnings.
Revenue
$274.95B
FY 2025 · Annual
+11.3% YoYOperating Income
$9.13B
FY 2025 · Annual
-3.1% YoYNet Income
$5.96B
FY 2025 · Annual
+73.5% YoYIncome Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 174.07B | 180.52B | 195.27B | 247.12B | 274.95B |
| Cost of Revenue | 151.12B | 157.02B | 170.09B | 221.16B | 248.97B |
| Gross Profit | 22.95B | 23.5B | 25.18B | 25.96B | 25.99B |
| Gross Margin | 13.2% | 13.0% | 12.9% | 10.5% | 9.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 12.79B | 13.05B | 14.32B | 14.57B | 14B |
| Operating Expenses | 15.01B | 15.05B | 16.64B | 16.55B | 16.86B |
| Depreciation & Amortization | 2.92B | 2.94B | 3.04B | 2.78B | 2.78B |
| EBITDA | 11.09B | 11.52B | 12.07B | 12.47B | 11.75B |
| EBITDA Margin | 6.4% | 6.4% | 6.2% | 5.0% | 4.3% |
| Operating Income | 7.94B | 8.45B | 8.54B | 9.42B | 9.13B |
| Operating Margin | 4.6% | 4.7% | 4.4% | 3.8% | 3.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.21B | 1.23B | 1.45B | 1.44B | 1.38B |
| Other Income / Expenses | (1.15B) | (53M) | (3.02B) | (4.15B) | (1.54B) |
| Income Before Tax | 6.79B | 8.4B | 5.51B | 5.27B | 7.59B |
| Pre-Tax Margin | 3.9% | 4.7% | 2.8% | 2.1% | 2.8% |
| Income Tax Expense | 1.37B | 1.62B | 141M | 1.49B | 1.35B |
| Net Income | 5.37B | 6.7B | 5.16B | 3.43B | 5.96B |
| Net Margin | 3.1% | 3.7% | 2.6% | 1.4% | 2.2% |
| EPS (Basic) | 15.89 | 21.66 | 17.57 | 12.25 | 22.30 |
| EPS (Diluted) | 15.75 | 21.41 | 17.39 | 12.12 | 22.17 |
| 337.96M | 313.07M | 296.88M | 280.29M | 265.95M | |
| 340.97M | 313.07M | 296.88M | 283.22M | 265.95M |
CI Earnings Waterfall · TTM
NYSE:CI · Revenue to Net Income
Key Ratios
EPS$22.66
Gross Margin10.3%
Net Margin2.1%
P/E Ratio12.2
P/S Ratio1.0
Analysis
$286.3B of revenue converted into $6.0B of net income for the selected period. Gross margin is 10.3% and net margin is 2.1%, showing how much revenue survives after costs and taxes. EPS is $22.66, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Oct 9, 2026 | |
| 8-K | Current report | Sep 30, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 8, 2026 |
How much revenue does CI generate?
Cigna Corporation (CI) reported $274.95B of revenue in fiscal 2025.
Is CI profitable?
Cigna Corporation (CI) reported $5.96B of net income, with a net margin of 2.2%.
Continue the stock analysis
Jump to another research area for this company.